Inferior Outcomes for Patients Transferred Between Surgical Stages for Knee Periprosthetic Joint Infection

J Arthroplasty. 2024 Feb;39(2):490-493. doi: 10.1016/j.arth.2023.08.012. Epub 2023 Aug 22.

Abstract

Background: Periprosthetic joint infection (PJI) in total knee arthroplasty may result in 2-stage revision surgery. There are limited data describing outcomes when the first stage is completed at an outside hospital and the patient is referred to a tertiary center. We hypothesized that patients have greater success when both surgeries occur at a single center.

Methods: There were 25 knee PJI patients who presented with an antibiotic spacer and had a minimum 2-year follow-up who were retrospectively identified at a single tertiary referral center from 2014 to 2021. A cohort matched for age, sex, body mass index, Elixhauser comorbidity measure, spacer type, infectious organism, and year of surgery was established with patients who had both stages completed at the investigating institution. Modified Delphi success criteria of no subsequent surgery or reinfection with any species were compared.

Results: The transferred group demonstrated a treatment success of 40% compared to 84% in the continuous group (P < .01). The transferred group was more likely to have an additional procedure between stages (44 versus 8%, P < .01), with a higher number of surgeries after primary total knee arthroplasty (4.8 versus 3.0, P < .01), between stages (1.4 versus 0.2, P < .01), and after second stage (0.8 versus 0.2, P = .03). The transferred group had longer durations between stages (20.1 versus 7.0 weeks, P < .01).

Conclusion: Patients who have PJIs transferred between stages demonstrated higher treatment failure. Surgeons should consider transfer early with a goal of continuous management by a single institution.

Keywords: arthroplasty, replacement, knee/adverse effects; arthroplasty, replacement, knee/methods; knee joint/surgery; prosthesis-related infections/surgery; prosthesis-related infections/therapy.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious* / etiology
  • Arthroplasty, Replacement, Knee* / adverse effects
  • Arthroplasty, Replacement, Knee* / methods
  • Humans
  • Knee Joint / surgery
  • Knee Prosthesis* / adverse effects
  • Prosthesis-Related Infections* / drug therapy
  • Prosthesis-Related Infections* / etiology
  • Prosthesis-Related Infections* / surgery
  • Reoperation / methods
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents